List of Excipients in Branded Drug ALAVERT ALLERGY

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALAVERT ALLERGY	loratadine	0573-2620	ANHYDROUS CITRIC ACID
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALAVERT ALLERGY	loratadine	0573-2620	ASPARTAME
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	ALAVERT ALLERGY	loratadine	0573-2620	CELLULOSE, MICROCRYSTALLINE

Generic Drugs Containing ALAVERT ALLERGY

Company	Ingredient	NDC	Excipient
Haleon US Holdings LLC	loratadine, pseudoephedrine sulfate	0573-2660	ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Haleon US Holdings LLC	loratadine, pseudoephedrine sulfate	0573-2660	CROSCARMELLOSE SODIUM
Haleon US Holdings LLC	loratadine, pseudoephedrine sulfate	0573-2660	HYPROMELLOSE

What are the Most Frequently-Used Excipients in ALAVERT ALLERGY?

# Of NDCs	Excipient

Excipient Strategy and Commercial Opportunities for ALAVERT ALLERGY

Last updated: February 27, 2026

What are the current excipient considerations for ALAVERT ALLERGY?

ALAVERT ALLERGY contains active ingredients such as cetirizine hydrochloride, and its formulation utilizes excipients optimized for stability, bioavailability, and patient safety. The formulation typically includes fillers, binders, disintegrants, lubricants, and flavoring agents designed to enhance patient compliance and extend shelf life. Common excipients may include microcrystalline cellulose, sodium starch glycolate, magnesium stearate, and flavoring agents like artificial or natural flavors.

How do excipient choices impact ALAVERT ALLERGY’s market performance?

Excipients influence drug stability, onset of action, and taste—factors vital for allergy medications. For instance:

• Microcrystalline cellulose ensures consistent disintegration, optimizing absorption.
• Disintegrants like sodium starch glycolate ensure rapid onset, crucial in allergy relief.
• Lubricants, such as magnesium stearate, facilitate manufacturing and improve product quality.

Strategic excipient selection can improve product shelf life, reduce manufacturing costs, and enhance patient satisfaction. The choice of excipients also affects regulatory approval processes; using GRAS (Generally Recognized As Safe) excipients accelerates registration.

What are the emerging trends and opportunities in excipient development for allergy drugs?

Emerging trends focus on natural, allergen-free, and biodegradable excipients. These trends address consumer demand for clean-label products and regulatory shifts toward safer, non-toxic excipients. Key areas include:

• Use of plant-based disintegrants and fillers.
• Development of excipients with improved stability to temperature and humidity, reducing distribution costs.
• Incorporation of taste-masking agents to improve palatability, especially in pediatric formulations.

These innovations offer opportunities to differentiate ALAVERT ALLERGY in a competitive market, particularly as consumers shift toward more natural and trusted ingredients.

How can excipient formulation strategies unlock commercial value?

Optimizing excipient selection enhances product stability, reduces manufacturing costs, and extends shelf life, all of which lower overall expenses and time-to-market. Clear benefits include:

• Enabling formulation of smaller or longer-lasting packages.
• Reducing batch failures due to excipient incompatibilities.
• Supporting flavor and texture improvements to increase patient adherence.

Partnering with excipient suppliers offering customized solutions, especially biodegradable or allergen-free options, opens avenues in targeted marketing—promoting safety, natural ingredients, and rapid onset.

What licensing and regulatory considerations influence excipient strategy?

The regulatory landscape, including FDA and EMA guidelines, emphasizes excipient safety and transparency. Manufacturers should:

• Use excipients documented in regulatory monographs.
• Provide detailed excipient safety data during submission.
• Prioritize excipients with established safety profiles to streamline approval processes.

Keeping consistent with current regulations minimizes delays and facilitates market expansion into regions with strict standards.

How can a robust excipient strategy lead to expansion into new markets?

Aligning excipient choices with regional regulatory expectations and consumer preferences improves acceptance. For example:

• In Europe, preference for non-allergenic and natural excipients.
• In Asia, formulations emphasizing flavor masking and stability.

Customizing excipient profiles to regional demands can support entry into emerging markets, bolster brand reputation, and optimize cost structures.

Key Takeaways

• Excipient selection affects ALAVERT ALLERGY’s stability, efficacy, and patient compliance.
• Trends toward natural, allergen-free, biodegradable excipients open new positioning channels.
• Optimized excipient strategies reduce manufacturing costs and facilitate regulatory approval.
• Using well-documented, safe excipients accelerates market entry and expansion.
• Regional consumer preferences influence excipient choices, aiding market penetration.

FAQs

1. Can natural excipients replace synthetic ones in ALAVERT ALLERGY?
Yes, natural excipients such as plant-based fillers or disintegrants can replace synthetic counterparts, aligning with consumer preferences and regulatory trends.

2. How does excipient choice impact drug shelf life?
Excipients influence drug stability and moisture sensitivity. Selecting stable excipients enhances shelf life and reduces waste.

3. What are the regulatory hurdles in changing excipients?
Regulatory agencies require safety data and justification for excipient changes. Documentation of safety profiles and stability data is essential.

4. Are there cost advantages to using biodegradable excipients?
Biodegradable excipients can reduce disposal costs and appeal to eco-conscious markets, though initial formulation adjustments may be needed.

5. How do flavoring agents influence consumer acceptance?
Flavoring agents mask bitterness and improve taste, especially beneficial in pediatric allergy formulations, increasing medication adherence.

---

References

1. U.S. Food and Drug Administration (FDA). (2021). Guidance for Industry: Excipients in Drug Products. https://www.fda.gov
2. European Medicines Agency (EMA). (2020). Guideline on Excipients in the Label and Package Leaflet of Medicinal Products.
3. International Pharmaceutical Excipients Council (IPEC). (2022). Global Excipients Market Report.